SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-23-013446
Filing Date
2023-04-27
Accepted
2023-04-27 12:47:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2023proxy-definitiveaddita.htm DEFA14A 10895
2 neoleukintherapeuticsinc001.jpg GRAPHIC 146521
3 neoleukintherapeuticsinc002.jpg GRAPHIC 139400
  Complete submission text file 0001628280-23-013446.txt   406042
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36327 | Film No.: 23853973
SIC: 2834 Pharmaceutical Preparations